BACE1 has long been known to have a significant role in the pathophysiology of the disease as the enzyme that cleaves amyloid precursor protein (APP) and produces amyloid-beta (Aβ) peptides, which assemble form plaques that are characteristic of AD. This evidence concerns the gene BACE1 and Alzheimer disease.